4.8 Article

Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1614336114

Keywords

multiple sclerosis; ALCAM; blood-brain barrier; EAE; tight junctions

Funding

  1. Multiple Sclerosis Society of Canada (MSSOC)
  2. Swiss National Science Foundation [133092]
  3. ProDoc Cell Migration
  4. Swiss MS Society
  5. Fonds de Recherche du Qubec-Sante
  6. MSSOC

Ask authors/readers for more resources

Activated leukocyte cell adhesion molecule (ALCAM) is a cell adhesion molecule found on blood-brain barrier endothelial cells (BBB-ECs) that was previously shown to be involved in leukocyte transmigration across the endothelium. In the present study, we found that ALCAM knockout (KO) mice developed a more severe myelin oligodendrocyte glycoprotein (MOG) 35-55-induced experimental autoimmune encephalomyelitis (EAE). The exacerbated disease was associated with a significant increase in the number of CNS-infiltrating proinflammatory leukocytes compared with WT controls. Passive EAE transfer experiments suggested that the pathophysiology observed in active EAE was linked to the absence of ALCAM on BBB-ECs. In addition, phenotypic characterization of unimmunized ALCAM KO mice revealed a reduced expression of BBB junctional proteins. Further in vivo, in vitro, and molecular analysis confirmed that ALCAM is associated with tight junction molecule assembly at the BBB, explaining the increased permeability of CNS blood vessels in ALCAM KO animals. Collectively, our data point to a biologically important function of ALCAM in maintaining BBB integrity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available